Transversus Abdominis Plane Block Versus Erector Spinae Plane Block

Sponsor
Hassan Mokhtar Elshorbagy Hetta (Other)
Overall Status
Completed
CT.gov ID
NCT03989570
Collaborator
(none)
100
1
3
9
11.1

Study Details

Study Description

Brief Summary

The TAP block, first described by Rafi in 2001, is comprised of deposition of a local anesthetic into the anatomical plane between the internal oblique and transverses abdominis muscles, where thess thoracoabdominal nerves (T6-L1) contribute to the main sensory supply of the skin, muscles, and parietal peritoneum of the anterior abdominal wall. These nerves branch and communicate extensively with each other in the TAP .

Erector spinae plane (ESP) block is a recently described interfascial block in which the local anaesthectic is placed over or below the plane of the erector spinae muscle, near where the spinal nerves come out from the spine before they start to divide. Some publications have shown its effectiveness in treating thoracic and abdominal postoperative pain.

Postoperative pain is the major obstacle for early postoperative ambulation and increases the risk of venous thromboembolism, respiratory complications and prolongs the hospital stay. Parietal pain is the chief component of postoperative pain after abdominal surgeries. Large doses of opioids are required to mitigate this pain, but they are poorly tolerated. Multimodal analgesia is effective in handling postoperative pain and in attenuating the side effects of large doses of a single analgesic .

Condition or Disease Intervention/Treatment Phase
  • Procedure: transversus abdominis plane block
  • Procedure: erector spinae plane block
  • Other: control group
N/A

Detailed Description

Group I (A group): Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side).

Group II (B group): Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side).

Group III (C group): anesthetized with the protocol followed by Minia University Hospital The medication will be prepared and supplied in similar syringes by an anesthetist not included in the management of the patint or data collection.

Methods:

Following placement of the standard monitors, intravenous access will secured and the patients will started on IV fluids. Anesthesia will be induced with 0.04 mg/kg midazolam, 2 μg/kg fentanyl, and titrated doses of propofol. Endotracheal intubation will facilitated with 0.5 mg/kg of atracurium. Isoflurane 1.2%, will be used for anesthetic maintenance After induction of anesthesia, stabilizing the patient's hemodynamics, and before surgical incision, ESB & TAP block will be performed. With the patient in the supine position, the site of the ultrasound and needle entry will be sterilized. The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected. Then the patient will turn in lateral position, the site of the ultrasound and needle entry will be sterilized. The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
Ultrasound Guided Transversus Abdominis Plane Block Versus Erector Spinae Plane Block in Patients Undergoing Emergency Laparotomies.
Actual Study Start Date :
May 15, 2019
Actual Primary Completion Date :
Feb 1, 2020
Actual Study Completion Date :
Feb 12, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group I (A group)

31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side).

Procedure: erector spinae plane block
The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes

Active Comparator: Group II (B group)

31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side).

Procedure: transversus abdominis plane block
The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected

Placebo Comparator: Group III (C group)

31 patients anesthetized with the protocol followed by Minia University Hospital

Other: control group
placebo

Outcome Measures

Primary Outcome Measures

  1. Time of First Post Operative Analgesic Request [24 hours]

    the pain will be assisted based on the time for the first dose of rescue analgesia

  2. Postoperative Total Fentanyl Requirement [24 hours]

    The total amount of postoperative fentanyl in milligram was given to the patient as rescue analgesia during 24 hours

Secondary Outcome Measures

  1. Incidence of Any Adverse Events [5 days]

    adverse events related to technique or drugs

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
    1. Age18-70 . 2. Both gender . 3 .Emergency laparotomies . 4. ASA I-III .
Exclusion Criteria:
  1. Drug allergy .

  2. Morbid obesity (BMI >40 kg/m2) .

  3. Psychiatric disorder .

  4. Opioid dependence .

  5. patient refuse

Contacts and Locations

Locations

Site City State Country Postal Code
1 Minia University Hospital Minya Egypt 61511

Sponsors and Collaborators

  • Hassan Mokhtar Elshorbagy Hetta

Investigators

  • Study Chair: Nagy S. Ali, MD, Minia University Hospital
  • Study Director: Abeer A Hassanien, Minia University Hospital

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Hassan Mokhtar Elshorbagy Hetta, assistant lecture, Minia University
ClinicalTrials.gov Identifier:
NCT03989570
Other Study ID Numbers:
  • 73-7/2018
First Posted:
Jun 18, 2019
Last Update Posted:
Jun 30, 2020
Last Verified:
Jun 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Hassan Mokhtar Elshorbagy Hetta, assistant lecture, Minia University
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail 7 patient refuse to participate
Arm/Group Title Group I (A Group) Group II (B Group) Group III (C Group)
Arm/Group Description 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo
Period Title: Overall Study
STARTED 31 31 31
COMPLETED 31 31 31
NOT COMPLETED 0 0 0

Baseline Characteristics

Arm/Group Title Group I (A Group) Group II (B Group) Group III (C Group) Total
Arm/Group Description 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo Total of all reporting groups
Overall Participants 31 31 31 93
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
45.8
(14.9)
47.4
(11.8)
43.6
(13.7)
45.61
(13.46)
Sex: Female, Male (Count of Participants)
Female
15
48.4%
14
45.2%
16
51.6%
45
48.4%
Male
16
51.6%
17
54.8%
15
48.4%
48
51.6%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
0
0%
0
0%
0
0%
0
0%
Not Hispanic or Latino
31
100%
31
100%
31
100%
93
100%
Unknown or Not Reported
0
0%
0
0%
0
0%
0
0%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
0
0%
0
0%
0
0%
Asian
0
0%
0
0%
0
0%
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
0
0%
0
0%
0
0%
Black or African American
0
0%
0
0%
0
0%
0
0%
White
31
100%
31
100%
31
100%
93
100%
More than one race
0
0%
0
0%
0
0%
0
0%
Unknown or Not Reported
0
0%
0
0%
0
0%
0
0%
Region of Enrollment (participants) [Number]
Egypt
31
100%
31
100%
31
100%
93
100%

Outcome Measures

1. Primary Outcome
Title Time of First Post Operative Analgesic Request
Description the pain will be assisted based on the time for the first dose of rescue analgesia
Time Frame 24 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Group I (A Group) Group II (B Group) Group III (C Group)
Arm/Group Description 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo
Measure Participants 31 31 31
Mean (Standard Deviation) [Hour]
14.9
(5.7)
6.5
(2.2)
2.8
(1.6)
2. Primary Outcome
Title Postoperative Total Fentanyl Requirement
Description The total amount of postoperative fentanyl in milligram was given to the patient as rescue analgesia during 24 hours
Time Frame 24 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Group I (A Group) Group II (B Group) Group III (C Group)
Arm/Group Description 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo
Measure Participants 31 31 31
Mean (Standard Deviation) [Milligram]
40.3
(26.7)
111
(38.1)
175
(38.9)
3. Secondary Outcome
Title Incidence of Any Adverse Events
Description adverse events related to technique or drugs
Time Frame 5 days

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Group I (A Group) Group II (B Group) Group III (C Group)
Arm/Group Description 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo
Measure Participants 31 31 31
Number [participants]
0
0%
0
0%
0
0%

Adverse Events

Time Frame 5 days
Adverse Event Reporting Description All patients were under control and receive the best care of management Our techniques don't make any side effects or affect patients outcome
Arm/Group Title Group I (A Group) Group II (B Group) Group III (C Group)
Arm/Group Description 31 patients Will undergo ESP block with 40 ml bupivacine 0.25% (20 ml on each side), and TAP block with 40 ml saline 0.9% (20 ml on each side). erector spinae plane block: The ESP block will be performed into a fascial plane between the deep surface of erector spinae muscle and the transverse processes 31patients Will undergo TAP block with 40 ml bupivacine 0.25% (20 ml on each side), and ESP block with 40 ml saline 0.9% (20 ml on each side). transversus abdominis plane block: The TAP block will be performed laterally behind the midaxillary line between the iliac crest and the most inferior extent of the ribs. The plane between the internal oblique and transversus abdominis muscle will be located around the midaxillary line with the probe transverse to the abdomen. Anteriorly,The needle will be passed to come in plane with the ultrasound beam and placed between transversus and internal oblique posterior to the midaxillary line then, the local anesthetic will be injected 31 patients anesthetized with the protocol followed by Minia University Hospital control group: placebo
All Cause Mortality
Group I (A Group) Group II (B Group) Group III (C Group)
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/31 (0%) 0/31 (0%) 0/31 (0%)
Serious Adverse Events
Group I (A Group) Group II (B Group) Group III (C Group)
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/31 (0%) 0/31 (0%) 0/31 (0%)
Other (Not Including Serious) Adverse Events
Group I (A Group) Group II (B Group) Group III (C Group)
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/31 (0%) 0/31 (0%) 0/31 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Hassan Elshorbagy
Organization Minia university
Phone 1204427271 ext 0020
Email Hassan.Hetta@mu.edu.eg
Responsible Party:
Hassan Mokhtar Elshorbagy Hetta, assistant lecture, Minia University
ClinicalTrials.gov Identifier:
NCT03989570
Other Study ID Numbers:
  • 73-7/2018
First Posted:
Jun 18, 2019
Last Update Posted:
Jun 30, 2020
Last Verified:
Jun 1, 2020